Enlarge this image

Dr. Deborah Birx, the White House’s coronavirus response coordinator, speaks during a briefing with the coronavirus task force at the White House on Thursday. The FDA has granted emergency use authorization for a second antibody treatment. Susan Walsh/AP

Susan Walsh/AP

One of the experimental drugs that President Trump received while he was battling the coronavirus has been approved for emergency use by the Food and Drug Administration. The drug, made by the biotech company Regeneron, is the second antibody treatment to win emergency use approval by the FDA.

The treatment combines two antibodies — casirivimab and imdevimab — and administers them together by IV. In a clinical trial of about 800 people, the cocktail was shown to significantly reduce virus

Read More At Article Source | Article Attribution